Patents by Inventor Danping Li

Danping Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240066556
    Abstract: A device for separating and recovering flat-plate catalyst powder and a method for determining a wear ratio are provided. The device includes a powder separation unit and a powder recovery unit, a powder accumulation bin is respectively connected with a shell and a catalyst powder outlet, a cyclone outlet is configured on an inner side of a recovery shell, and a primary filter and a secondary filter are configured on an inner side wall of the recovery shell.
    Type: Application
    Filed: June 29, 2023
    Publication date: February 29, 2024
    Inventors: Yingjie Bao, Jieyong Hao, Changkai Yu, Xun Wu, Xianchun Zhou, Yanxuan Liang, Rongfu Tang, Feiyun Chen, Bin Luo, Kaiyou Liao, Danping Zhang, Chao Li, Fanhai Kong, Lele Wang, Qiang Bao, Chuan He
  • Publication number: 20220265636
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: August 18, 2021
    Publication date: August 25, 2022
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Publication number: 20220193045
    Abstract: The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: March 4, 2022
    Publication date: June 23, 2022
    Inventors: Wolfram EISENREICH, Nadia S. LADYZHYNSKY, Danping LI, Leon SCHULTZ, Zeren WANG, Sreeraj MACHA, Albert BARTA
  • Publication number: 20200237744
    Abstract: The present invention relates to pharmaceutical compositions comprising a quinolone carboxylic acid derivative antimicrobial agent and an effervescent agent. These compositions have improved gastrointestinal tolerability and/or reduced potential to cause gastrointestinal side effects. These compositions are useful for oral administration, for treating, preventing, or reducing the risk of microbial infections.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 30, 2020
    Inventor: Danping LI
  • Publication number: 20200022971
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: May 29, 2019
    Publication date: January 23, 2020
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Patent number: 10300046
    Abstract: The present invention relates to pharmaceutical compositions useful for administration for treating, preventing, or reducing the risk of microbial infections.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: May 28, 2019
    Assignee: MELINTA SUBSIDIARY CORP.
    Inventor: Danping Li
  • Publication number: 20180289678
    Abstract: The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: June 11, 2018
    Publication date: October 11, 2018
    Inventors: Wolfram EISENREICH, Nadia S. LADYZHYNSKY, Danping LI, Leon SCHULTZ, Zeren WANG, Sreeraj MACHA, Albert BARTA
  • Publication number: 20170368055
    Abstract: The present invention relates to methods for treating, preventing, or reducing the risk of microbial infections while minimizing adverse gastrointestinal effects using a two-stage dosing regimen comprising about 1 to about 7 days of intravenous administration followed by about 1 to about 14 days of oral administration of an antimicrobial agent.
    Type: Application
    Filed: September 6, 2017
    Publication date: December 28, 2017
    Inventors: Danping LI, Scott J. HOPKINS, Jarrod LONGCOR
  • Publication number: 20160374995
    Abstract: The present invention relates to pharmaceutical compositions useful for administration for treating, preventing, or reducing the risk of microbial infections.
    Type: Application
    Filed: September 9, 2016
    Publication date: December 29, 2016
    Inventor: Danping LI
  • Publication number: 20160235736
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: February 12, 2016
    Publication date: August 18, 2016
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Patent number: 9409896
    Abstract: The present invention relates to carrier systems useful for pharmaceutical compositions. These carriers comprise an emulsifier, and also in further embodiments a polymeric dissolution aid. These carriers are useful for delivering pharmaceutical actives such as antimicrobial agents.
    Type: Grant
    Filed: November 1, 2011
    Date of Patent: August 9, 2016
    Assignee: Melinta Therapeutics, Inc.
    Inventors: Eric S. Burak, Danping Li, David S. Dresback
  • Publication number: 20150366858
    Abstract: The present invention relates to methods for treating, preventing, or reducing the risk of microbial infections while minimizing adverse gastrointestinal effects using a two-stage dosing regimen comprising about 1 to about 7 days of intravenous administration followed by about 1 to about 14 days of oral administration of an antimicrobial agent.
    Type: Application
    Filed: June 19, 2015
    Publication date: December 24, 2015
    Inventors: Danping LI, Scott J. Hopkins, Jarrod Longcor
  • Publication number: 20150366857
    Abstract: The present invention relates to pharmaceutical compositions comprising a quinolone carboxylic acid derivative antimicrobial agent and an effervescent agent. These compositions have improved gastrointestinal tolerability and/or reduced potential to cause gastrointestinal side effects. These compositions are useful for oral administration, for treating, preventing, or reducing the risk of microbial infections.
    Type: Application
    Filed: June 19, 2015
    Publication date: December 24, 2015
    Inventor: Danping LI
  • Publication number: 20150165040
    Abstract: The present invention relates to pharmaceutical compositions useful for administration for treating, preventing, or reducing the risk of microbial infections.
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Inventors: Eric S. Burak, Danping Li
  • Publication number: 20140094463
    Abstract: The present invention relates to carrier systems useful for pharmaceutical compositions. These carriers comprise an emulsifier, and also in further embodiments a polymeric dissolution aid. These carriers are useful for delivering pharmaceutical actives such as antimicrobial agents.
    Type: Application
    Filed: November 1, 2011
    Publication date: April 3, 2014
    Applicant: RIB-X PHARMACEUTICALS, INC.
    Inventors: Eric S. Burak, Danping Li, David S. Dresback
  • Publication number: 20140088164
    Abstract: The present invention relates to pharmaceutical compositions useful for administration for treating, preventing, or reducing the risk of microbial infections.
    Type: Application
    Filed: November 21, 2011
    Publication date: March 27, 2014
    Applicant: Rib-X Pharmaceuticals, Inc.
    Inventor: Danping Li
  • Publication number: 20140057928
    Abstract: This invention relates to novel sodium salt forms of the following Compound (1), and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:
    Type: Application
    Filed: October 30, 2013
    Publication date: February 27, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Rolf-Stefan BRICKL, Shirlynn CHEN, Jihchin CHUNG, Mayur Suryakant DUDHEDIA, Danping LI, Zhi-Hui LU, Siddharthya MUJUMDAR, Chitra TELANG, Richard J. VARSOLONA, Zeren WANG
  • Patent number: 8598183
    Abstract: This invention relates to novel sodium salt forms of the following Compound (1), and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: December 3, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Rolf-Stefan Brickl, Shirlynn Chen, Jihchin Chung, Mayur Suryakant Dudhedia, Danping Li, Zhi-Hui Lu, Siddharthya Mujumdar, Chitra Telang, Richard J. Varsolona, Zeren Wang
  • Publication number: 20120208857
    Abstract: The present invention relates to pharmaceutical compositions useful for administration for treating, preventing, or reducing the risk of microbial infections.
    Type: Application
    Filed: October 12, 2010
    Publication date: August 16, 2012
    Inventors: Eric S. Burak, Danping Li
  • Publication number: 20120122887
    Abstract: This invention relates to novel sodium salt forms of the following Compound (1), and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:
    Type: Application
    Filed: September 23, 2011
    Publication date: May 17, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Rolf-Stefan BRICKL, Shirlynn CHEN, Jihchin CHUNG, Mayur Suryakant DUDHEDIA, Danping LI, Zhi-Hui LU, Siddharthya MUJUMDAR, Chitra TELANG, Richard J. VARSOLONA, Zeren WANG